Federal Supply Schedule 36F79726D020E

This Federal Supply Schedule award represents an Interim Agreement under General Services Administration (GSA) Schedule 65, Item B, establishing OWP Pharmaceuticals, Inc. as a multiple-award contractor for the supply of drugs, pharmaceuticals, and hematology-related products. The contract was awarded on February 1, 2026, to Veterans Integrated Service Network (VISN) 12, a civilian component of the Department of Veterans Affairs responsible for managing healthcare delivery across a regional network of Veterans Affairs medical facilities. With a ceiling value of $25,000, this interim agreement provides the contracting agency with access to pharmaceutical and hematological supplies to support veteran healthcare services across the VISN 12 region through the contract's ultimate completion date of July 31, 2026. No small business set-asides were utilized in this multiple-award procurement vehicle.

As an interim agreement under FSS Schedule 65, this contract establishes the terms, conditions, and pricing framework through which VISN 12 medical facilities may issue task orders to procure pharmaceutical and hematology-related products from OWP Pharmaceuticals, Inc. The scope encompasses drugs and related pharmaceutical products necessary for clinical administration within the Veterans Affairs healthcare system, particularly products supporting hematological therapies and treatments. The multiple-award structure indicates that other contractors hold concurrent agreements for identical or similar supplies, allowing VISN 12 to leverage competition and ensure continuity of supply for critical pharmaceutical and hematology products needed to deliver healthcare services to the veteran population served by the network.